MyoCon! Early Bird Pricing Ends July 1st.Living with myositis is not only a physical challenge—it is deeply emotional. New research presented at the 2026 Global Conference on Myositis (GCOM) by TMA and in partnership with Keenova…
Continue Reading
Exploring the “Power Plants” in JDM
Christian Lood, PhD is an Associate Professor in the Division of Rheumatology at the University of Washington. He was awarded a grant through TMA’s Research Grants Program for a project…
Continue Reading
Beyond Positive or Negative
By Julio Huapaya, MD As a pulmonologist who takes care of patients with myositis, one of the most difficult challenges I face when discussing their illness, is how unpredictable their…
Continue Reading
TMA Research Grants Fuel Discovery
Ten years ago, the treatment landscape for myositis diseases was, let’s be honest, bleak. We had no FDA-approved treatments for myositis. Only one or two clinical trials were available to…
Continue Reading
New Hope for Those with Myositis
By Theresa Curry Early next year, biopharmaceutical company Priovant Therapeutics, an affiliate of Roivant Sciences, plans to file for FDA approval of brepocitinib. If approved, the drug could become the…
Continue Reading